Full Text
PNP3 COST-BENEFIT ANALYSIS OF ALMOTRIPTAN FROM A SOCIETAL PERSPECTIVE, USING CLINICAL TRIAL OUTCOMES

Abstract

Authors

SY Kwon AG Hartzema

Back to Volume 5, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×